Nazario Pio Tenace (Nazario P Tenace)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Neoadjuvant Chemotherapy

Small Cell Lung Cancer

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Matilde Simoni, Chiara Menegazzi, Cristina Fracassi, Claudia C Biffi, Francesca Genova, Nazario Pio Tenace, Roberta Lucianò, Andrea Raimondi, Carlo Tacchetti, James Brugarolas, Davide Mazza, Rosa Bernardi
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO molecular medicine 16 (6) (2024)
Matilde Simoni, Chiara Menegazzi, Cristina Fracassi, Claudia C Biffi, Francesca Genova, Nazario Pio Tenace, Roberta Lucianò, Andrea Raimondi, Carlo Tacchetti, James Brugarolas, Davide Mazza, Rosa Bernardi
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO molecular medicine 16 (6) (2024)
Matilde Simoni, Chiara Menegazzi, Cristina Fracassi, Claudia C Biffi, Francesca Genova, Nazario Pio Tenace, Roberta Lucianò, Andrea Raimondi, Carlo Tacchetti, James Brugarolas, Davide Mazza, Rosa Bernardi
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO molecular medicine 16 (6) (2024)
Matilde Simoni, Chiara Menegazzi, Cristina Fracassi, Claudia C Biffi, Francesca Genova, Nazario Pio Tenace, Roberta Lucianò, Andrea Raimondi, Carlo Tacchetti, James Brugarolas, Davide Mazza, Rosa Bernardi
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO molecular medicine (2024)
Matilde Simoni, Chiara Menegazzi, Cristina Fracassi, Claudia C Biffi, Francesca Genova, Nazario Pio Tenace, Roberta Lucianò, Andrea Raimondi, Carlo Tacchetti, James Brugarolas, Davide Mazza, Rosa Bernardi
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma. EMBO molecular medicine 16 (6) (2024)
João Lobo, Nazario Pio Tenace, Sofia Cañete-Portillo, Isa Carneiro, Rui Henrique, Roberta Lucianò, Lara R Harik, Cristina Magi-Galluzzi
Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall. Histopathology (2023)